The Future of DTC Genomics and the Law

被引:9
作者
Greely, Henry T. [1 ,2 ,3 ]
机构
[1] Stanford Univ, Law, Stanford, CA 94305 USA
[2] Stanford Univ, Genet, Stanford, CA 94305 USA
[3] Stanford Univ, Ctr Law & Biosci, Stanford, CA 94305 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1177/1073110520917003
中图分类号
B82 [伦理学(道德学)];
学科分类号
摘要
Direct-to-Consumer ("DTC") genomics has been a controversial topic for over a decade. Much work has been done on the legal issues it raises. This article asks a different question: What will DTC genomics and its legal issues look like in ten to twenty years? After discussing the five current uses of DTC genomics, it describes three current legal issues: medical uses, privacy of genomic information, and privacy in collection and analysis of human DNA. It then suggests that changes in human genomics and how it is used will make the first of those DTC genomics legal issues less important in the future, but that the third will be increasingly significant.
引用
收藏
页码:151 / 160
页数:10
相关论文
共 56 条
  • [1] Aldhouse P., 2019, BUZZFEED NEWS 0519
  • [2] [Anonymous], 2019, GENOMEWEB 0926
  • [3] [Anonymous], 2014, MIT TECHNOLOGY REV
  • [4] [Anonymous], 2017, MOL GENET GENOMICS, V5, P621
  • [5] [Anonymous], 2013, COMMUNICATION 1122
  • [6] [Anonymous], 2019, ATLANTIC
  • [7] [Anonymous], 2012, GENOMEWEB 0717
  • [8] Baden-Lasar E., NY TIMES MAGAZINE
  • [9] Begley S, 2019, Stat.
  • [10] Brown Kristen V., 2018, GIZMODO